SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krishna Institute of Medical Sciences rises on acquiring 51% stake in Spanv Medisearch Lifescience

13 Sep 2022 Evaluate

Krishna Institute of Medical Sciences is currently trading at Rs. 1254.15, up by 15.80 points or 1.28% from its previous closing of Rs. 1238.35 on the BSE.

The scrip opened at Rs. 1267.00 and has touched a high and low of Rs. 1272.10 and Rs. 1246.05 respectively. So far 1809 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1532.15 on 04-Jan-2022 and a 52 week low of Rs. 1060.05 on 26-Oct-2021.

Last one week high and low of the scrip stood at Rs. 1300.00 and Rs. 1225.15 respectively. The current market cap of the company is Rs. 10047.89 crore.

The promoters holding in the company stood at 38.84%, while Institutions and Non-Institutions held 31.14% and 30.01% respectively.

Krishna Institute of Medical Sciences has acquired 51% stake in Spanv Medisearch Lifescience (Kingsway Hospitals) and the shares of the Kingsway Hospitals were credited in the Demat A/c of the Company. Earlier, the company had entered into a definitive agreement to acquire a majority stake in Spanv Medisearch Lifescience.

Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.

Krishna Inst.Medi Share Price

717.55 10.00 (1.41%)
08-May-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×